Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
3,831,000
|
4,191,000
|
3,736,000
|
4,443,000
| Cost of Revenue | 1,063,000 | 1,075,000 | 987,000 | 1,245,000 | |
Gross Profit
|
2,768,000
|
3,116,000
|
2,749,000
|
3,198,000
| |
|
Operating Expenses |
|
Research Development | 930,000 | 1,082,000 | 951,000 | 962,000 |
|
Selling General and Administrative | 1,183,000 | 1,355,000 | 1,238,000 | 1,228,000 |
|
Non Recurring |
-
| 51,000 | 1,909,000 | (130,000) |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
655,000
|
628,000
|
(1,349,000)
|
1,138,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 19,000 | 35,000 | 50,000 | (189,000) |
|
Earnings Before Interest And Taxes | 674,000 | 513,000 | (1,259,000) | 1,059,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 674,000 | 513,000 | (1,259,000) | 1,059,000 |
|
Income Tax Expense | 51,000 | (411,000) | (546,000) | 251,000 |
|
Minority Interest | (14,000) | 1,000 | 2,000 | (163,000) |
|
|
|
Net Income From Continuing Ops | 609,000 | 775,000 | (671,000) | 755,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
609,000
|
925,000
|
(711,000)
|
645,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
609,000
|
925,000
|
(711,000)
|
645,000
|
|